Clinical Trial

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

Name: Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer — clinical trial record (NCT07643012)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADAPT-EC

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the safety, tolerability, and preliminary efficacy of moderately hypofractionated (15-fraction) MR-guided adaptive pelvic IMRT in patients with endometrial cancer.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-07

Trial Details

NCT Number	NCT07643012
Lead Sponsor	Rutgers, The State University of New Jersey
Conditions	Endometrial Cancer
Enrollment	30 participants
Start Date	2026-06-09
Primary Completion	2029-06 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-06